Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis

B cells cultured with anti-IgM, BSF-p1, and B15-TRF will differentiate into high rate IgM-synthesizing cells in the presence of supernatants from EL-4 cells that have been induced with phorbol myristate acetate. These supernatants contain two molecular species (EL-TRFs) that have differentiative activity. One co-migrates with interleukin 2 (IL-2) and its activity is blocked by antibody to the IL-2 receptor. Furthermore, molecularly cloned IL-2, at concentrations of 100 U/ml or more, expresses such EL-TRF activity. The EL-TRF activity of cloned IL-2 can also be inhibited by antibody to the IL-2 receptor. The other material with EL-TRF activity has a molecular weight of approximately 32,000. This material lacks IL-2 activity. Antibody to the IL-2 receptor does not impair its function. B cells stimulated with anti-IgM and BSF-p1, with or without B15-TRF, express determinants that react with two monoclonal antibodies which recognize distinct epitopes on the T cell IL-2 receptor. These determinants are present at much lower density (approximately 100-fold) on stimulated B cells that on HT-2 cells, an IL-2-dependent T cell line. Very small amounts of [3H]IL-2 (less than 1,000 molecules per cell) bind to activated B cells. These results indicate that IL-2 binds to a receptor on appropriately prepared B cells and causes them to differentiate into high rate IgM-synthesizing cells. The physiologic significance of the B cell differentiative activity of IL-2 remains to be investigated.

• Publication year

  1984

• Venue

  Journal of Experimental Medicine

• Publication date

  1984-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1084/JEM.160.6.1605PMID 6439814PMCID 2187531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nomenclature for lymphokines regulating B lymphocytes.

  1984cited by this paper
• Ig RNA expression in normal B cells stimulated with anti-IgM antibody and T cell-derived growth and differentiation factors

  1984cited by this paper
• The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

  1984cited by this paper
• Interleukin-2 receptors on activated malignant and normal B-cells.

  1984cited by this paper
• Development of a human T-T cell hybridoma secreting B cell growth factor

  1983cited by this paper
• Interleukin 2 induces antigen-reactive T cell lines to secrete BCGF-I

  1983cited by this paper
• Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.

  1983cited by this paper
• Transient expression of interleukin 2 receptors. Consequences for T cell growth

  1983influential reference
• B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation

  1983cited by this paper
• Production and characterization of monoclonal antibodies to human interleukin 2: strategy and tactics.

  1983cited by this paper
• Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

  1983cited by this paper
• An avidin--biotin microELISA for rapid measurement of total and allergen-specific human IgE.

  1983cited by this paper
• Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).

  1983cited by this paper
• Biochemical and physicochemical characterization of mouse B cell growth factor: a lymphokine distinct from interleukin 2.

  1983cited by this paper
• Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

  1983cited by this paper
• Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.

  1982cited by this paper
• A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor

  1982cited by this paper
• Identification of a T cell-derived b cell growth factor distinct from interleukin 2

  1982influential reference
• Monoclonal Antibodies Against Rat Immunoglobulin Kappa Chains

  1982cited by this paper
• Separable helper factors support B cell proliferation and maturation to Ig secretion.

  1982cited by this paper
• Development of a human T-T-cell hybridoma secreting B-cell growth factor (BCGF)

  1982cited by this paper
• T cell growth factor receptors. Quantitation, specificity, and biological relevance

  1981cited by this paper
• Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.

  1981cited by this paper
• B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor

  1981cited by this paper
• A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody.

  1981cited by this paper
• Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.

  1980cited by this paper
• Discrimination of a colony stimulating factor subclass by a specific receptor on a macrophage cell line

  1980cited by this paper
• Two mRNAs with different 3' ends encode membrane-bound and secreted forms of immunoglobulin mu chain.

  1980cited by this paper
• Thymoma production of T cell growth factor (Interleukin 2).

  1980cited by this paper
• Continuous proliferation of murine antigen-specific helper T lymphocytes in culture

  1979cited by this paper
• Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response

  1978cited by this paper
• "Panning" for lymphocytes: a method for cell selection.

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Letter to the editor

  1967cited by this paper

• Immune functions in untreated and treated multiple sclerosis patients

  2012cites this paper
• Die Rolle von ICOS auf die B-Zelldifferenzierung in einem in vivo Modell

  2009cites this paper
• Current Concepts in Immunology

  2009cites this paper
• Brief Definitive Report Administration of Recombinant Interleukin 2 in Vivo Induces a Polyclonal Igm Response

  2003cites this paper
• Characterization of CD4+ CTLs Ex Vivo1

  2002influential citation
• Effect of Halococcus morrhuae and Halobacterium saccharovorum on the activation of human peripheral blood lymphocytes.

  1999cites this paper
• Immune functions in untreated and treated multiple sclerosis patients

  1999cites this paper
• ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28

  1999cites this paper
• Interleukin-18: a novel cytokine that augments both innate and acquired immunity.

  1998cites this paper
• Lymphokines and Cytokines

  1998cites this paper
• Requirement of cytokines for augmentation of the antigen-specific antibody responses by ascorbate in cultured murine T-cell-depleted splenocytes.

  1998cites this paper
• Biology of the interleukin-2 receptor.

  1998cites this paper
• Signaling from the IL-2 receptor to the nucleus.

  1997cites this paper
• Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.

  1997cites this paper
• IL-4 and anti-CD40 protect against Fas-mediated B cell apoptosis and induce B cell growth and differentiation.

  1996cites this paper
• Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells.

  1996cites this paper
• Control of the IL-2 responsiveness of B lymphocytes by IL-2 and IL-4.

  1995cites this paper
• Interleukin-2: its rationale and role in the treatment of patients with cancer.

  1995cites this paper
• IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo.

  1995cites this paper
• Purification to homogeneity of a novel human B cell differentiation factor.

  1995cites this paper
• Identification and characterization of IL-2 hyper-responsive NZB/WF1 CD5- B cells.

  1994cites this paper
• Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system.

  1994cites this paper
• Lowest dose interleukin-2 immunotherapy.

  1993cites this paper
• IL‐2 enhances polyclonal IgM but not IgM‐rheumatoid factor synthesis by activated human peripheral blood B cells

  1993cites this paper
• Local lymph node assay: study of the in vitro proliferation and control of the specificity of the response by FACScan analysis.

  1993cites this paper
• Interleukin-2: its biology and clinical application in patients with cancer.

  1993cites this paper
• Ability of tolerized Th1 and Th2 clones to stimulate B cell activation and cell cycle progression.

  1992cites this paper
• IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes.

  1992cites this paper
• A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene.

  1992cites this paper
• Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth.

  1992cites this paper
• Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens

  1992cites this paper
• Functional studies of cytokines produced by Xenopus Lymphocytes following T cell mitogen stimulation

  1992cites this paper
• Interleukin-2: counteracting pleiotropy by compartmentalization.

  1991cites this paper
• Interleukin-2, autotolerance, and autoimmunity.

  1991cites this paper
• Expression of IL-2 receptor p55 and p75 chains by human B lymphocytes: effects of activation and differentiation.

  1991cites this paper
• Glycosylphosphatidylinositol: a candidate system for interleukin-2 signal transduction.

  1991cites this paper
• Regulation of the B cell response by cytokines

  1991cites this paper
• The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.

  1991cites this paper
• Interleukin 2- and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter.

  1991cites this paper
• Lymphokine-regulated differential expression of mRNA for p75kDa-IL-2R and p55kDa-IL-2R in a cloned B lymphoma line (BLC1-CL-3 cells).

  1990cites this paper
• 7 – Immunoglobulin isotype regulation

  1990cites this paper
• Cells and mediators which participate in immunoglobulin synthesis by human mononuclear cells. III. Null cells secrete a factor(s) (human immunoglobulin synthesis/secretion‐facilitating factor) that can replace the null cells in the synthesis of immunoglobulin by cultured B cells

  1990cites this paper
• 4 – Rôle of cytokines in the ontogeny, activation and proliferation of B lymphocytes

  1990cites this paper
• Antigen-specific sIalo B cells do not secrete IgG2a in response to TH1 cells and antigen: responsiveness can be restored by IL-4.

  1990cites this paper
• 5 – Cytokine regulation of B-cell differentiation

  1990cites this paper
• IL-5 up-regulates but IL-4 down-regulates IL-2R expression on a cloned B lymphoma line.

  1990cites this paper
• Characterization of a neoplastic B cell clone that secretes IgM in response to Th2-derived lymphokines.

  1990cites this paper
• Induction of tumoricidal activity and alterations of growth by interleukin-2 and manipulation of protein kinase C and cytosolic calcium in childhood acute lymphocytic leukemia cells.

  1989cites this paper
• Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains

  1989cites this paper
• Interleukin 2 and interferon-gamma affect human B cells at different stages of activation.

  1989cites this paper
• B cell response pathways regulated by IL-5 and IL-2. Secretory microH chain-mRNA and J chain mRNA expression are separately controlled events.

  1989cites this paper
• 18 – The Immunoglobulin Helper: The J Chain

  1989cites this paper
• Cognate interactions between helper T cells and B cells. I. Cloning and helper activity of a lymphokine-dependent helper T cell clone (Th-3).

  1989cites this paper
• 4 – Recombinant Cytokines and their Therapeutic Value in Veterinary Medicine

  1989cites this paper
• Effects of interleukins 1, 2 and 3 on follicle-stimulating hormone-induced differentiation of rat granulosa cells.

  1989cites this paper
• Regulation of IgM production in thermally injured patients.

  1989cites this paper
• Interleukin 2 and interferon‐γ affect human B cells at different stages of activation

  1989cites this paper
• Mechanism of interleukin-2 signaling: mediation of different outcomes by a single receptor and transduction pathway.

  1989cites this paper
• Interleukin 2 regulates antigen-specific immunoglobulin response of naive murine B cells.

  1989cites this paper
• Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.

  1989cites this paper
• Control of the immune response at the level of antigen-presenting cells: a comparison of the function of dendritic cells and B lymphocytes.

  1989cites this paper
• Cellular interactions in the humoral immune response.

  1989cites this paper
• The interleukin 2 receptor.

  1989cites this paper
• Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig.

  1989cites this paper
• Interleukin-2: inception, impact, and implications.

  1988cites this paper
• 'B-cell factors' are pleiotropic.

  1988cites this paper
• Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.

  1988cites this paper
• Murine B lymphoma cell lines release functionally active interleukin 2 after stimulation with Staphylococcus aureus.

  1988cites this paper
• The Human Interleukin‐2 Receptor

  1988cites this paper
• The Role of IL4 and IL5: Characterization of a Distinct Helper T Cell Subset that makes IL4 and IL5 (Th2) and Requires Priming before Induction of Lymphokine Secretion

  1988cites this paper
• Induction of differentiation in human leukemic b cells by interleukin 2 alone: differential effect on the expression of μ and j chain genes

  1988cites this paper
• Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts

  1988cites this paper
• Differential effects of interleukin 2 vs B cell growth factor on human B cells.

  1988cites this paper
• Both B151-T cell replacing factor 1 and IL-5 regulate Ig secretion and IL-2 receptor expression on a cloned B lymphoma line.

  1988cites this paper
• Suppressor factor secreted by T hybridoma established from peripheral blood lymphocytes of a bone marrow transplantation patient. I. Establishment of human T-cell hybridoma and partial characterization of suppressor factor.

  1988cites this paper
• The role of recombinant IL-2 and IL-1 in murine B cell differentiation.

  1988cites this paper
• Pre-B cell generation potentiated by soluble factors from a bone marrow stromal cell line.

  1988cites this paper
• T Cell‐Replacing Factor (TRF)/Interleukin 5 (IL‐5): Molecular and Functional Properties

  1988cites this paper
• Supernatant from a cloned helper T cell stimulates resting B cells to express transferrin and IL-2 receptors.

  1987cites this paper
• Single cell studies on the role of B-cell stimulatory factor 1 in B-cell activation.

  1987cites this paper
• The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.

  1987cites this paper
• Regulation of human B lymphocyte activation, proliferation, and differentiation.

  1987cites this paper
• Interleukin 2 mediates an alteration in the T200 antigen expressed on activated B lymphocytes.

  1987cites this paper
• Regulation of B‐Lymphocyte Activation, Proliferation, and Differentiation

  1987cites this paper
• T dependent induction of an IgA and IgM anti-polysaccharide response.

  1987cites this paper
• Control of the Cell Cycle of Murine B Lymphocytes: The Nature of α‐ and β‐B‐Cell Growth Factors and of B‐Cell Maturation Factors

  1987cites this paper
• Interleukin 2 inhibits in vitro granulocyte-macrophage colony formation.

  1987cites this paper
• Simultaneous occurrence of chronic granulocytic leukemia and chronic lymphoid leukemia.

  1987cites this paper
• The interleukin 2 receptor. Functional consequences of its bimolecular structure

  1987cites this paper
• 9 – B Cell and T Cell Growth Factors

  1987cites this paper
• Cytogenetic aspects of B-cell chronic lymphocytic leukemia: their correlation with clinical stage and different polyclonal mitogens.

  1987cites this paper
• Analysis of T cell‐replacing factor‐like activity: potent induction of T helper activity for human B cells by residual concanavalin A and interleukin 2

  1987cites this paper
• Interleukin-2 effects on human B cells activatedin vivo

  1987cites this paper
• Comparative activation requirements of human peripheral blood, spleen, and lymph node B cells.

  1987cites this paper
• Induction of IgG2a secretion from mIgG2a+ B-lymphoid tumor cells by BCDF present in several antigen-specific T-helper clones.

  1987cites this paper
• A Role for IFN‐γ and NK Cells in Immune Responses to T Cell‐Regulated Antigens Types 1 and 2

  1987cites this paper
• T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.

  1987cites this paper
• Demonstration of up-regulated IL 2 receptor expression on an in vitro cloned BCL1 subline.

  1987cites this paper
• MODE OF ACTION OF ANTIGEN‐SPECIFIC T‐CELL HELPER FACTORS SECRETED BY A T‐CELL LINE AND CLONES

  1987cites this paper
• Interleukin 4 (IgG1 induction factor): a multifunctional lymphokine acting also on T cells

  1987cites this paper